Genetically engineered soybean in EU court: Civil society against Monsanto & Co please support us!
A broad coalition against another patent on chimpanzees
Thirteen organisations from Germany, Switzerland and Great Britain are about to file a joint opposition against a patent on genetically engineered chimpanzees granted to the US company, Altor. Patent EP1409646 was granted by the European Patent Office (EPO) in June 2012. It allows chimpanzees to be manipulated to make their DNA similar to that of humans, and then used in pharmaceutical research. The joint opposition argues that this patent violates ethical provisions in patent law.
Munich/ Berlin 01.02.2013
Today in Berlin a new report was published presenting a critical assessment of the consequences of the commercial cultivation of genetically engineered plants in the US. The first genetically engineered plants were created 30 years ago in Europe and the US. Commercial growing in the USA began almost 20 years ago, but in the EU, acceptance of these crops is much lower. Nevertheless, companies are asking for further authorisations for cultivation, including in the EU. In the light of this development, past experience in the USA was assessed and recommendations made for the future handling of this technology in the EU. Some of the principal findings are:
Munich/ New Delhi 29.01.13
Testbiotech analysed data on the genetically engineered maize MON89034 x NK603 presented by the US company Monsanto to the Indian authorities. The plants, so called stacked events, are produced by crossing two genetically engineered plants. The maize produces two insecticidal toxins and is herbicide-tolerant. One of the insecticidal proteins is derived from a synthetic DNA that does not occur in nature.